The Settlement Administrator is commencing the distribution process to eligible claimants. Consumers with a valid claim are being sent an initial email to the email address provided on the Claim Form with instructions on how to redeem payment through the digital payment process. Within the next 30 to 45 days, a second email will be sent with a live link to redeem the digital payment and the amount of the payment. Payment amounts will not be available until you receive that second email. If you have any questions about your claim or the claim process, or you would like to confirm your email address, please contact the Settlement Administrator by email at info@EpiPenClassAction.com or call 1-877-221-7632.
Please continue to check the website for further updates.
A Settlement of $264,000,000 has been reached between the Class Plaintiffs and the Mylan Defendants
(which are Mylan N.V., Mylan Specialty L.P., Mylan Pharmaceuticals Inc., Viatris Inc., or Heather Bresch). This Settlement is separate from
the settlement with the Pfizer Defendants. Additional information on the Pfizer Settlement is available on the Pfizer Settlement page of
this website.
The Court has not decided whether Mylan Defendants did anything wrong. For additional details and answers to frequently asked questions,
please read the Long-Form Notice.
UPDATE:
On July 11, 2022 and July 21, 2022, the Court entered Final Judgments and Orders in this matter. Copies of these documents are available for review on the Court Documents page of this website.
The Settlement Administrator is continuing to process claim forms. Claimants that provided deficient claim forms and/or require additional information to substantiate their claims will be notified in the upcoming weeks. Please note that all claims must be finalized prior to distribution. If you have any questions about your claim or the claim process please contact the Settlement Administrator by email at info@EpiPenClassAction.com or call 1-877-221-7632.
Who is Included?
If you are a person or entity in the United States who paid or provided reimbursement for some or all of the purchase price of Branded or authorized generic EpiPens for the purpose of consumption, and not resale, by yourself, your family member(s), insureds, plan participants, employees, or beneficiaries, at any time between August 24, 2011, and November 1, 2020, and did not exclude yourself from the Class during the initial notice period, you are a Class Member. The exceptions to being included in the Class are detailed in the Settlement Agreement.
This is the only way to be eligible to receive a payment from the Settlement.
Proofs of Claim must be postmarked (if mailed) or
received (if submitted online) on or before July 25, 2022
.
If you already submitted a Proof of Claim form during the settlement with the Pfizer Defendants in 2021 in this case, you do not
need to do anything.
You will automatically be included as a member of the settlement with Mylan using the claim form you already
submitted in 2021. No further action is needed on your part.
If you did not already submit a Proof of Claim form in this case in 2021 during the settlement with the Pfizer Defendants, you will
need to submit a Proof of Claim form.
The deadline to submit Proofs of Claim has passed.
Write to the Court and explain why you object to the Settlement, the Plan of Allocation, and/or the request for attorneys’ fees,
expenses, or service awards. Objections must be filed with the Court and received by the parties on or before June 8, 2022.
The deadline to submit an objection has passed.
Ask to speak in Court about the fairness of the Settlement.
Requests to speak must be filed with the Court and served on the parties on
or before June 8, 2022. If you submit a written objection, you may (but you do not have to) attend the hearing.
The deadline to file a Notice of Intention to Appear has passed.
If you already submitted a claim in this case for the Settlement with the Pfizer Defendants in 2021, you need not submit a second claim now.
More Information
This website contains a summary of the Settlement and relevant Court papers. For answers to frequently asked questions, please read the Long-Form Notice. You can also review relevant Decisions and Orders and additional information about this action and the Settlement by accessing the "Court Documents" page of this website. Complete copies of all public pleadings, Court rulings, and other filings are available for review by accessing the Court docket in this case, for a fee, through the Court’s Public Access to Court Electronic Records (PACER) system at https://ecf.ksd.uscourts.gov, or visiting the office of the Clerk of the Court for the United States District Court for the District of Kansas, 500 State Avenue, Kansas City, KS 66101, between 9:00 a.m. and 4:00 p.m., Monday through Friday, excluding Court holidays.
